Liver fibrosis: mechanisms of immune-mediated liver injury

被引:0
|
作者
Ruonan Xu
Zheng Zhang
Fu-Sheng Wang
机构
[1] Liver Disease Research Center for Biological Therapy,
[2] Beijing 302 Hospital,undefined
来源
关键词
cirrhosis; hepatic stellate cell; liver fibrosis;
D O I
暂无
中图分类号
学科分类号
摘要
Liver fibrosis and its end-stage consequence, cirrhosis, represent the final common pathway of virtually all chronic liver diseases. Research into hepatic stellate cell activation, imbalance of the extracellular matrix synthesis and degradation and the contribution of cytokines and chemokines has further elucidated the mechanisms underlying fibrosis. Furthermore, clarification of changes in host adaptive and innate immune systems has accelerated our understanding of the association between liver inflammation and fibrosis. Continued elucidation of the mechanisms of hepatic fibrosis has provided a comprehensive model of fibrosis progression and regression. This review summarizes the current concepts of improvements that have been made in the field of fibrosis.
引用
收藏
页码:296 / 301
页数:5
相关论文
共 50 条
  • [31] The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury
    Tai Rao
    Ya-ting Liu
    Xiang-chang Zeng
    Chao-peng Li
    Dong-sheng Ou-Yang
    Acta Pharmacologica Sinica, 2021, 42 : 27 - 35
  • [32] Immune-mediated liver injury following COVID-19 vaccination
    Georgios Schinas
    Eleni Polyzou
    Vasiliki Dimakopoulou
    Stamatia Tsoupra
    Charalambos Gogos
    Karolina Akinosoglou
    World Journal of Virology, 2023, (02) : 100 - 108
  • [33] Pembrolizumab-Induced Liver Injury: Beyond Immune-Mediated Hepatitis
    Herms, Queralt
    Fuster-Anglada, Carla
    Juanola, Adria
    GASTROENTEROLOGY, 2024, 167 (03) : 443 - 445
  • [34] Protective Effects of Ursodeoxycholic Acid against Immune-Mediated Liver Fibrosis in Rats
    Zhang, Li-Xin
    Liang, Tie-Jun
    Tan, Yan-Rong
    Ren, Wan-Hua
    Han, Guo-Qing
    Zhang, Jie
    Wang, Lai-Cheng
    Qin, Cheng-Yong
    HEPATO-GASTROENTEROLOGY, 2010, 57 (102-03) : 1196 - 1202
  • [35] Profiles of Immune Cells and Reproduction of Immune-mediated Drug-induced Liver Injury
    Fujisaka, Yasuyuki
    Kondo, Yasuteru
    Sasaki, Takamitsu
    Kogure, Takayuki
    Inoue, Jun
    Nakagome, Yu
    Wakui, Yuuta
    Iwata, Tomoaki
    Morosawa, Tatsuki
    Umetsu, Teruyuki
    Suzuki, Hiroyuki
    Yamaguchi, Hiroaki
    Mano, Nariyasu
    Nagata, Kiyoshi
    Shimosegawa, Tooru
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S871 - S871
  • [36] Mechanisms of immune checkpoint inhibitor-mediated liver injury
    Shojaie, Layla
    Ali, Myra
    Iorga, Andrea
    Dara, Lily
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (12) : 3727 - 3739
  • [37] Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate-Adaptive Immune-Mediated Tissue Inflammation
    Zhai, Y.
    Busuttil, R. W.
    Kupiec-Weglinski, J. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (08) : 1563 - 1569
  • [38] ISONIAZID-INDUCED LIVER INJURY IN HUMANS IS IMMUNE-MEDIATED AND NOT "METABOLIC IDIOSYNCRASY"
    Metushi, Imir G.
    Uetrecht, Jack P.
    DRUG METABOLISM REVIEWS, 2014, 45 : 48 - 49
  • [39] Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors
    Fontana, Robert J.
    Li, Yi-Ju
    Chen, Vincent
    Kleiner, David
    Stolz, Andrew
    Odin, Joe
    Vuppalanchi, Raj
    Gu, Jiezhun
    Dara, Lily
    Barnhart, Huiman
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (09)
  • [40] Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice
    Sass, G
    Koerber, K
    Bang, R
    Guehring, H
    Tiegs, G
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (04): : 439 - 447